Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension

Journal of Nutritional Biochemistry

Volumn 19, Issue 12, 2008, Pages 833-839

  Yang, Hsin Yi ^a   Yang, Suh Ching ^a   Chen, Shu Tzu ^a   Chen, Jiun Rong ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiotensin converting enzyme; Cardiovascular remodeling; Hypertension; Nitric oxide; Soy protein; Tumor necrosis factor

Indexed keywords

ALDEHYDE; DIPEPTIDYL CARBOXYPEPTIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN HYDROLYSATE; SOYBEAN PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; FOOD INTAKE; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HYPERTENSION; INGESTION; MALE; MYOCARDITIS; NONHUMAN; PLASMA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; AORTA; ASPARTATE AMINOTRANSFERASES; BLOOD PRESSURE; HYDROLYSIS; HYPERTENSION; LIPIDS; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRATES; NITRITES; RATS; RATS, WISTAR; SOYBEAN PROTEINS; VENTRICULAR REMODELING;

RATTUS;

EID: 55249084446     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.11.004     Document Type: Article

References (37)

1. Zhou M.S., Schulman I.H., and Raij L. Nitric oxide, angiotensin II, and hypertension. Semin Nephrol 24 (2004) 366-378
2. Koyanagi M., Egashira K., Kubo-Inoue M., Usui M., Kitamoto S., Tomita H., et al. Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. Hypertension 35 (2000) 86-90
3. Sharifi A.M., Akbarloo N., and Darabi R. Investigation of local ACE activity and structural alterations during development of l-NAME-induced hypertension. Pharmacol Res 52 (2005) 438-444
4. Pereira L.M., Bezerra D.G., Machado D.L., and Mandarim-de-Lacerda C.A. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats. Clin Sci (Lond) 106 (2004) 337-343
5. Katoh M., Egashira K., Mitsui T., Chishima S., Takeshita A., and Narita H. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol 32 (2000) 73-83
6. Zhang X., Shu X.O., Gao Y.T., Yang G., Li Q., Li H., et al. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133 (2003) 2874-2878
7. Chen S.T., Yang H.Y., Huang H.Y., Peng S.J., and Chen J.R. Effects of various soya protein hydrolysates on lipid profile, blood pressure and renal function in five-sixths nephrectomized rats. Br J Nutr 96 (2006) 435-441
8. Matsui T., Li C.H., Tanaka T., Maki T., Osajima Y., and Matsumoto K. Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol Pharm Bull 23 (2000) 427-431
9. Mallikarjun Gouda K.G., Gowda L.R., Rao A.G., and Prakash V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J Agric Food Chem 54 (2006) 4568-4573
10. Yang H.Y., Yang S.C., Chen J.R., Tzeng Y.H., and Han B.C. Soyabean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats. Br J Nutr 92 (2004) 507-512
11. Graciano M.L., Cavaglieri Rde C., Delle H., Dominguez W.V., Casarini D.E., Malheiros D.M., et al. Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15 (2004) 1805-1815
12. Hernandez-Ledesma B., Martin-Alvarez P.J., and Pueyo E. Assessment of the spectrophotometric method for determination of angiotensin-converting-enzyme activity, influence of the inhibition type. J Agric Food Chem 51 (2003) 4175-4179
13. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 (2001) 62-71
14. Aebi H. Catalase in vitro. Methods Enzymol 105 (1984) 121-126
15. Griesmacher A., Kindhauser M., Andert S.E., Schreiner W., Toma C., Knoebl P., et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98 (1995) 469-475
16. Raij L. Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension 37 (2001) 767-773
17. Ono Y., Ono H., Matsuoka H., Fujimori T., and Frohlich E.D. Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR. Hypertension 34 (1999) 609-616
18. Ceconi C., Fox K.M., Remme W.J., Simoons M.L., Bertrand M., Parrinello G., et al. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 73 (2007) 237-246
19. De Gennaro Colonna V., Rigamonti A., Fioretti S., Bonomo S., Manfredi B., Ferrario P., et al. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in l-NAME-induced hypertensive rats. Eur J Pharmacol 516 (2005) 253-259
20. Khattab M.M., Mostafa A., and Al-Shabanah O. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat. Kidney Blood Press Res 28 (2005) 243-250
21. Kim S., and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52 (2000) 11-34
22. Suda O., Tsutsui M., Morishita T., Tasaki H., Ueno S., Nakata S., et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol 24 (2004) 1682-1688
23. Minamino T., Kitakaze M., Papst P.J., Ueda Y., Sakata Y., Asanuma H., et al. Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats. Cardiovasc Drugs Ther 14 (2000) 533-542
24. Takemoto M., Egashira K., Tomita H., Usui M., Okamoto H., Kitabatake A., et al. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension 30 (1997) 1621-1627
25. Katoh M., Egashira K., Usui M., Ichiki T., Tomita H., Shimokawa H., et al. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. Circ Res 83 (1998) 743-751
26. McFarlane S.I., Kumar A., and Sowers J.R. Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol 91 (2003) 30H-37H
27. Heneman K.M., Chang H.C., Prior R.L., and Steinberg F.M. Soy protein with and without isoflavones fails to substantially increase postprandial antioxidant capacity. J Nutr Biochem 18 (2007) 46-53
28. Flesch M., Hoper A., Dell'Italia L., Evans K., Bond R., Peshock R., et al. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 108 (2003) 598-604
29. Pandolfi A., Cetrullo D., Polishuck R., Alberta M.M., Calafiore A., Pellegrini G., et al. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 21 (2001) 1378-1382
30. Thogersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., Huhtasaari F., et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98 (1998) 2241-2247
31. Brown N.J., Muldowney III J.A., and Vaughan D.E. Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition. Hypertension 47 (2006) 441-448
32. Kaikita K., Fogo A.B., Ma L., Schoenhard J.A., Brown N.J., and Vaughan D.E. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation 104 (2001) 839-844
33. Garcia-Estan J., Ortiz M.C., O'Valle F., Alcaraz A., Navarro E.G., Vargas F., et al. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats. Clin Sci (Lond) 110 (2006) 227-233
34. Shin Z.I., Yu R., Park S.A., Chung D.K., Ahn C.W., Nam H.S., et al. His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo. J Agric Food Chem 49 (2001) 3004-3009
35. Saito Y., Wanezaki K., Kawato A., and Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotechnol Biochem 58 (1994) 1767-1771
36. Lo W.M., and Li-Chan E.C. Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J Agric Food Chem 53 (2005) 3369-3376
37. Chen J.R., Okada T., Muramoto K., Suetsuna K., and Yang S.C. Identification of angiotensin I-converting enzyme inhibitory peptides derived from the peptic digest of soybean protein. J food Biochem 26 (2003) 543-554